Back to News
Market Impact: 0.3
EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades
Source: benzinga.com
Regulation & LegislationHealthcare & BiotechProduct LaunchesCompany Fundamentals
Modular Medical (NASDAQ: MODD) said the FDA cleared software enhancements to its Pivot insulin delivery system. The clearance supports continued commercialization and iteration of its device platform, which is modestly positive for sentiment around product progress. No financial impact figures were provided in the announcement.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
MODD0.45
More News
- Microsoft AI Focused Data Center Plan to Add 26 Gigawatts of Compute
- Jensen Huang explains why Nvidia will grow an astounding 70% next year
- Oracle's stock jumps 7% on earnings beat as cloud infrastructure revenue more than doubles
- Kaplan Fox Reminds Investors of DICK s Sporting Goods, Inc. (NYSE: DKS) to a Securities Class Action Deadline - Contact the Firm Before November 3, 2026
- Kaplan Fox Announces a Securities Class Action Filed Against Hims & Hers Health, Inc. (NYSE: HIMS) - Lead Plaintiff Deadline is November 2, 2026
- Tsakos Energy Navigation (TEN) Q2 2026 Earnings Call Transcript